Kelly Scrantz, MD
Neurological Surgery · Baton Rouge, LANPI 1760447882
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $127,200 of the $127,826 with a category attached, or 99.5%. Baton Rouge Surgical Services, LLC accounts for 99.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $127,228 and has fallen 99.8% since, to $304 in 2025. Among neurological surgery clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 13 payments — averaging $9832.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Baton Rouge Surgical Services, LLC$127K
- Carlsmed, Inc.$253
- Abbott$101
- Providence Medical Technology, Inc.$76
- Stryker$69
- Innovation Technologies Inc$27
- plus $100 from 5 others
What the payments were for
- Food & beverage$6260%
- Ownership interest$127,200100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Baton Rouge Surgical Services, LLC | 1 | $127,200 |
| Carlsmed, Inc. | 3 | $253 |
| Abbott | 1 | $101 |
| Providence Medical Technology, Inc. | 1 | $76 |
| Stryker | 1 | $69 |
| Innovation Technologies Inc | 1 | $27 |
| Globus Medical | 1 | $27 |
| Johnson & Johnson | 1 | $23 |
| Zimmer Biomet | 1 | $22 |
| Vertiflex, Inc. | 1 | $15 |
| Aesculap, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$101
How this compares
$127,826 in reported general payments places this provider in the 90th percentile of 116 neurological surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 100 | $1,128 |
| Methocarbamol | 76 | $557 |
| Meloxicam | 93 | $210 |
| Tizanidine Hcl | 19 | $155 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Baton Rouge
- Eric OberlanderBaton Rouge$660K
- Charles BowieBaton Rouge$60K
- Paul WaguespackBaton Rouge$43K
- Gregory FauthereeBaton Rouge$20K
- Brandon GaynorBaton Rouge$7K
- Garrett VenableBaton Rouge$6K
- Richard StangerBaton Rouge$6K
- Anthony SinShreveport$1.5M
- Sebastian KogaHammond$720K
- Najeeb ThomasMetairie$440K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.